Skip to main content

Animations

MJFF Publications

3331 - 3340 of 6570 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2023
  • 2011
  • 2019
  • 2023
  • 2026
  • 2015
  • 2019
  • 2018
  • Summary Details
    OPEN
    Title: TOX3 Variants Are Involved in Restless Legs Syndrome and Parkinson’s Disease with Opposite Effects
    Journal Name: Journal of Molecular Neuroscience
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s12031-018-1031-4
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Optical Structural Analysis of Individual α‐Synuclein Oligomers
    Journal Name: Angewandte Chemie
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/ange.201710779
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Early and Accurate Diagnosis of Parkinson Disease May Be Rooted in Seed Amplification Assays
    Journal Name: Clinical Chemistry
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/clinchem/hvad111
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Rotigotine in the Long-Term Treatment of Severe RLS with Augmentation: A Series of 28 Cases
    Journal Name: Sleep Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2011/468952
    Citation Count: 10
  • Summary Details
    OPEN
    Title: Serotonergic pathology and disease burden in the premotor and motor phase of A53T α-synuclein parkinsonism: a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30140-1
    Citation Count: 100
  • Summary Details
    OPEN
    Title: Progression of clinical markers in prodromal Parkinson’s disease and dementia with Lewy bodies: a multicentre study
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/brain/awad072
    Citation Count: 127
  • Summary Details
    OPEN
    Title: Clinically advanced NLRP3 inhibitor modulates microglial transcriptome and alleviates α-synuclein-induced progression of parkinsonism
    Journal Name: Journal of Neuroinflammation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12974-026-03716-3
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Acoustic Coordinated Reset Neuromodulation in a Real Life Patient Population with Chronic Tonal Tinnitus
    Journal Name: BioMed Research International
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2015/569052
    Citation Count: 26
  • Summary Details
    OPEN
    Title: The second generation mixed lineage kinase-3 (MLK3) inhibitor CLFB-1134 protects against neurotoxin-induced nigral dopaminergic neuron loss
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2019.05.002
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4)
    Journal Name: Journal of Neuropathology & Experimental Neurology
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/jnen/nly056
    Citation Count: 37
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.